The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Beauty Health (SKIN) International Revenue Performance Explored

The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.

The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript

The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.

The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company reports third quarter 2024 financial results. Improved profitability reflects early success of strategic initiatives.

BeautyHealth Reports Third Quarter 2024 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial™, will report third quarter 2024 financial results on Tuesday, November 12.

BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024

LONG BEACH, Calif.--(BUSINESS WIRE)--Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS).

Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, names Ron Menezes Chief Revenue Officer and Carrie Caulkins Chief Marketing Officer.

The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

LONG BEACH, Calif.--(BUSINESS WIRE)--Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results.

Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results

At Moats and Monopolies, we focus on long only, high quality businesses but sometimes we like a little asymmetric risk/reward opportunity. The Beauty Health Company has been incredibly volatile over the past couple of years as investors have grown weary that the company may never be profitable. The company still isn't profitable, causing a sell off after earnings after a $17 million write off for replacing flagship models with technical issues combined with declining revenues.

The Beauty Health Company Q2 2024 Earnings: Will It Ever Be Profitable?

The Beauty Health Company (NASDAQ:SKIN ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Michael Monahan - CFO Conference Call Participants Alec Legg - Canaccord Genuity Allen Gong - JPMorgan Macauley Kilbane - William Blair Joseph Federico - Stifel Neil Goh - TD Cowen Operator Good afternoon, and welcome to The Beauty Health Company Second Quarter 2024 Earnings Conference Call. [Operator Instructions].

The Beauty Health Company (SKIN) Q2 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Beauty Health (SKIN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Beauty Health (SKIN) Q2 Earnings: A Look at Key Metrics

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, announced 2024 second quarter financial results, including net sales of $90.6 million.

BeautyHealth Reports Second Quarter 2024 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company will report second quarter 2024 financial results after market close on Thursday, August 8, 2024.

BeautyHealth to Report Second Quarter 2024 Financial Results on August 8, 2024

New CEO Marla Beck seems to be a rational and competent leader with the experience needed to turn a product into a decent company. The Q1 2024 Earnings are a mixed bag, but there may be light at the end of the tunnel, as the company is slowly ameliorating the Syndeo 3 rollout debacle. Newly appointed COO Sheri Lewis is an experienced operator with a good resume and hopefully can sort out the supply chain issues that the company has faced.

The Beauty Health Company Q1 2024 Earnings: Sitting Pretty Or Turning Ugly?

The Beauty Health Company (NASDAQ:SKIN ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Norberto Aja – Investor Relations Marla Beck – Chief Executive Officer Mike Monahan – Chief Financial Officer Conference Call Participants Oliver Chen – TD Cowen Allen Gong – JPMorgan Susan Anderson – Canaccord Genuity Olivia Tong – Raymond James Joe Federico – Stifel Korinne Wolfmeyer – Piper Sandler Operator Hello, and welcome to The Beauty Health First Quarter 2024 Earnings Conference Call. At this time, all participants will be in a listen-only mode.

The Beauty Health Company (SKIN) Q1 2024 Earnings Call Transcript

The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings

The Beauty Health Company (SKIN) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.04 per share a year ago.

The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company reports first quarter financial results, with net sales of $81.4 million. Repurchases $192.3 million of convertible notes.

BeautyHealth Reports First Quarter 2024 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial™, will report first quarter 2024 financial results after market close on May 9, 2024.

BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, has appointed Sheri Lewis as Chief Supply Chain and Operations Officer.

BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

Moats and Monopolies focuses on long only, high quality businesses but occasionally likes to dabble in contrarian turnaround stories. The Beauty Health Company recently saw a single day 60%+ drop, after botching a new product launch, losing their CEO and refusing to answer analyst questions.

The Beauty Health Company: A Turnaround Post Earnings?

The Beauty Health Company (SKIN) Q4 2023 Earnings Call Transcript

The headline numbers for The Beauty Health Company (SKIN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, The Beauty Health Company (SKIN) Q4 Earnings: A Look at Key Metrics

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, reports full year and fourth quarter 2023 financial results.

BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company Board of Directors has appointed Marla Beck as the Company's permanent President and Chief Executive Officer.

News for The Beauty Health Company Stock (SKIN)